Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014

被引:19
|
作者
Guan, Qi [4 ]
Khuu, Wayne [2 ]
Spithoff, Sheryl [5 ]
Kiran, Tara [1 ,2 ,7 ]
Kahan, Meldon [7 ]
Tadrous, Mina [1 ,2 ,4 ]
Martins, Diana [2 ]
Leece, Pamela [3 ,5 ,7 ]
Gomes, Tara [1 ,2 ,4 ,6 ]
机构
[1] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada
[2] Inst Clin Evaluat Sci, Vet Hill Trail,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada
[3] Publ Hlth Ontario, Suite 300,480 Univ Ave, Toronto, ON M5G 1V2, Canada
[4] Univ Toronto, Leslie Dan Fac Pharm, 144 Coll St, Toronto, ON M5S 3M2, Canada
[5] Womens Coll Hosp, 76 Grenville St, Toronto, ON M5S 1B2, Canada
[6] Univ Toronto, Inst Hlth Policy Management & Evaluat, 155 Coll St, Toronto, ON M5T 3M6, Canada
[7] Univ Toronto, Dept Family & Community Med, 500 Univ Ave, Toronto, ON M5G 1V7, Canada
基金
加拿大健康研究院;
关键词
Methadone; Buprenorphine; Opioid prescribing; Opioid agonist treatment; Opioid use disorder; GINI COEFFICIENT; USE DISORDERS; BUPRENORPHINE; METHADONE; THERAPY; MANAGEMENT; ABSTINENCE; RETENTION; PROGRAMS;
D O I
10.1016/j.drugalcdep.2017.05.002
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Despite concerns surrounding high patient volumes in methadone clinics, little is known about the practice patterns of opioid maintenance therapy (OMT) providers in Ontario. We examined the distribution of these services and how physician characteristics differ based on prescribing volume. Methods: We conducted a cross-sectional study among prescribers of methadone or buprenorphine to Ontario public drug beneficiaries in 2014 by stratifying physicians into low- (lower 50%), moderate- (51-89%) and high volume (top 10%) prescribers. We summarized the distribution of OMT prescription days dispensed and urine drug screens (UDS) ordered using Lorenz curves and examined physician characteristics using descriptive statistics. Results: We identified 893 OMT prescribers in 2014. Physicians were mostly male (67.5%; N = 603), and middle-aged (median was 50). High-volume methadone providers (N = 57) prescribed approximately 56% (N = 4,115,322) of the total days of methadone (Gini coefficient = 0.76, 95% CI 0.74-0.79) while high-volume buprenorphine providers (N = 64) prescribed 61% (N = 589,463) of the total days of buprenorphine (Gini coefficient = 0.78, 95% CI 0.75-0.80). On average, each high-volume methadone prescriber treated 435 OMT patients and billed 43 UDS per patient, while each high-volume buprenorphine prescriber treated 64 OMT patients and billed 22 UDS per patient. Daily OMT patient volume was on average 74 for high-volume methadone prescribers and 6 for high-volume buprenorphine prescribers. Conclusions: OMT services are highly concentrated among a small portion of OMT providers who carry high daily patient volumes. Future research should examine the quality of primary care received by their patients to better elucidate the possible consequences of this highly unequal distribution of services.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 50 条
  • [21] Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
    Morin, Kristen A.
    Vojtesek, Frank
    Acharya, Shreedhar
    Marsh, David C.
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [22] Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study
    Russell, Cayley
    Nafeh, Frishta
    Pang, Michelle
    MacDonald, Shanna Farrell
    Derkzen, Dena
    Rehm, Jurgen
    Fischer, Benedikt
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [23] Opioid Prescribing by Primary Care Providers: a Cross-Sectional Analysis of Nurse Practitioner, Physician Assistant, and Physician Prescribing Patterns
    M. James Lozada
    Mukaila A. Raji
    James S. Goodwin
    Yong-Fang Kuo
    Journal of General Internal Medicine, 2020, 35 : 2584 - 2592
  • [24] A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions
    Ling, Sara
    Mangaoil, Remar
    Cleverley, Kristin
    Sproule, Beth
    Puts, Martine
    DRUG AND ALCOHOL DEPENDENCE, 2019, 197 : 168 - 182
  • [25] Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study
    Bukten, Anne
    Skurtveit, Svetlana
    Gossop, Michael
    Waal, Helge
    Stangeland, Per
    Havnes, Ingrid
    Clausen, Thomas
    ADDICTION, 2012, 107 (02) : 393 - 399
  • [26] Opioid Prescribing by Primary Care Providers: a Cross-Sectional Analysis of Nurse Practitioner, Physician Assistant, and Physician Prescribing Patterns
    Lozada, M. James
    Raji, Mukaila A.
    Goodwin, James S.
    Kuo, Yong-Fang
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (09) : 2584 - 2592
  • [27] Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients
    Launonen, Essiina
    Alho, Hannu
    Kotovirta, Elina
    Wallace, Isla
    Simojoki, Kaarlo
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (09) : 875 - 882
  • [28] Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment: A Comparison of Methadone Maintenance and Office-based Buprenorphine
    Rastegar, Darius A.
    Kawasaki, Sarah Sharfstein
    King, Van L.
    Harris, Elizabeth E.
    Brooner, Robert K.
    SUBSTANCE USE & MISUSE, 2016, 51 (07) : 803 - 811
  • [29] Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
    Burden, A. M.
    Paterson, J. M.
    Solomon, D. H.
    Mamdani, M.
    Juurlink, D. N.
    Cadarette, S. M.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (03) : 1075 - 1082
  • [30] Benzodiazepine prescription for patients in opioid maintenance treatment in Norway
    Bramness, Jorgen G.
    Kornor, Hege
    DRUG AND ALCOHOL DEPENDENCE, 2007, 90 (2-3) : 203 - 209